Daniel T. Ginat, MD MS

American Board of Radiology, Certificate of Added Qualification, Neuroradiology
Certification
2014

Massachussetts General Hospital
Boston
- Neuroradiology Fellowship
2013

University of Rochester Medical Center
Rochester, NY
Residency - Diagnostic Radiology
2011

American Board of Radiology
Certification
2011

Columbia University
New York, NY
MS - Biomedical Engineering
2006

New York University School of Medicine
New York, NY
MD - Medicine
2005

Columbia University
New York, NY
BS - Biomedical Engineering
2001

A postmortem high-resolution MRI study of the development of cochlear nerve-related structures in the second and third trimesters of pregnancy.
A postmortem high-resolution MRI study of the development of cochlear nerve-related structures in the second and third trimesters of pregnancy. Quant Imaging Med Surg. 2024 Sep 01; 14(9):6325-6336.
PMID: 39281173

Imaging Features of Ectopic Nasopharyngeal Branchial Cleft Cyst With Temporal Bone Involvement.
Imaging Features of Ectopic Nasopharyngeal Branchial Cleft Cyst With Temporal Bone Involvement. Ear Nose Throat J. 2024 Aug 08; 1455613241271727.
PMID: 39115135

Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review.
Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review. Diagnostics (Basel). 2024 Aug 01; 14(15).
PMID: 39125542

Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab.
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab. Cancer Gene Ther. 2024 Oct; 31(10):1477-1485.
PMID: 39085630

Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial.
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
PMID: 38842838

Imaging features and surgical management of giant parathyroid adenoma with autoinfarction.
Imaging features and surgical management of giant parathyroid adenoma with autoinfarction. J Clin Imaging Sci. 2024; 14:9.
PMID: 38628608

Advances in the Radiological Evaluation of and Theranostics for Glioblastoma.
Advances in the Radiological Evaluation of and Theranostics for Glioblastoma. Cancers (Basel). 2023 Aug 18; 15(16).
PMID: 37627190

Recent Advances in Deep Learning and Medical Imaging for Head and Neck Cancer Treatment: MRI, CT, and PET Scans.
Recent Advances in Deep Learning and Medical Imaging for Head and Neck Cancer Treatment: MRI, CT, and PET Scans. Cancers (Basel). 2023 Jun 21; 15(13).
PMID: 37444376

Early Postoperative Magnetic Resonance Imaging Findings Related to Electrocauterization for Cerebellar Reduction During Chiari Decompression Surgery.
Early Postoperative Magnetic Resonance Imaging Findings Related to Electrocauterization for Cerebellar Reduction During Chiari Decompression Surgery. J Comput Assist Tomogr. 2023 Jun 12.
PMID: 37311666

Early Postoperative Magnetic Resonance Imaging Findings Related to Electrocauterization for Cerebellar Reduction During Chiari Decompression Surgery.
Early Postoperative Magnetic Resonance Imaging Findings Related to Electrocauterization for Cerebellar Reduction During Chiari Decompression Surgery. J Comput Assist Tomogr. 2023 Sep-Oct 01; 47(5):782-785.
PMID: 37707409

ASNR Computer Sciences and Information Committee

ASNR Young Professionals Committee